Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

BACKGROUND AND OBJECTIVE: Indacaterol/glycopyrronium (IND/GLY) 110/50 μg once daily (q.d.) has demonstrated greater improvements in lung function, patient‐reported outcomes and lower exacerbation rates versus mono long‐acting muscarinic antagonists (LAMA) in chronic obstructive pulmonary disease (CO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respirology
Main Authors: Muro, Shigeo, Yoshisue, Hajime, Kostikas, Konstantinos, Olsson, Petter, Gupta, Pritam, Wedzicha, Jadwiga A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155057/
https://ncbi.nlm.nih.gov/pubmed/31339215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/resp.13651
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados